Journal of Inflammation-London, published by BMC, is a premier open access journal dedicated to advancing the understanding of inflammation, a critical process underlying numerous diseases including autoimmune disorders, cancer, and cardiovascular conditions. With its inception in 2004, the journal has consistently delivered high-quality research that bridges basic science and clinical applications, maintaining a significant place in the academic community. It holds impressive rankings within the Q2 category for both Cell Biology and Clinical Biochemistry, reflecting its impactful contributions to these fields, where it ranks in the 73rd and 64th percentiles respectively. The journal is committed to open access principles, ensuring that all published articles are freely available to researchers, practitioners, and the global community, thereby fostering collaboration and innovation. Located in the United Kingdom, the journal continues to attract submissions from prominent researchers and institutions worldwide, solidifying its status as an essential resource for the latest developments in inflammation research.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

Addicta - The Turkish Journal on Addictions, published by the esteemed Turkish Green Crescent Society, is an open access journal dedicated to advancing the understanding of addictions and their implications on mental health. Since its inception in 2019, this journal has become a significant platform for interdisciplinary research, focusing on the biological, psychological, and sociocultural aspects of addiction. With a focus on both empirical studies and theoretical discussions, Addicta seeks to foster a greater understanding of addiction as a complex phenomenon, facilitating knowledge sharing among researchers, practitioners, and policymakers. The journal has achieved notable rankings, residing in the Q4 category in Biological Psychiatry and Psychiatry and Mental Health, and Q3 in miscellaneous Psychology, marking its growing impact in the field. Accessing its content is completely free, making important research accessible to a broader audience. Based in Turkey, Addicta provides a vital resource for those interested in the nuances of addiction research, promoting innovative solutions and fostering collaboration across disciplines.

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.